| 注册
首页|期刊导航|国际肝胆胰疾病杂志(英文版)|Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis

Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis

Ba(s)ak Gümü(s) Güler Sibel Özler

国际肝胆胰疾病杂志(英文版)2020,Vol.19Issue(3):271-276,6.
国际肝胆胰疾病杂志(英文版)2020,Vol.19Issue(3):271-276,6.

Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis

Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis

Ba(s)ak Gümü(s) Güler 1Sibel Özler2

作者信息

  • 1. Department of Health Sciences, Istinye University, Istanbul 34010, Turkey
  • 2. Department of Perinatology, Selcuk University Faculty of Medicine, Konya 42130, Turkey
  • 折叠

摘要

关键词

Intrahepatic cholestasis of pregnancy/Syndecan-1/Glypican-3/Adverse perinatal outcome/Response to UDCA

Key words

Intrahepatic cholestasis of pregnancy/Syndecan-1/Glypican-3/Adverse perinatal outcome/Response to UDCA

引用本文复制引用

Ba(s)ak Gümü(s) Güler,Sibel Özler..Increased syndecan-1 and glypican-3 predict poor perinatal outcome and treatment resistance in intrahepatic cholestasis[J].国际肝胆胰疾病杂志(英文版),2020,19(3):271-276,6.

国际肝胆胰疾病杂志(英文版)

OACSCDSCI

1499-3872

访问量1
|
下载量0
段落导航相关论文